Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial
Article first published online: 18 JAN 2012
© 2011 Blackwell Publishing Ltd
Diabetes, Obesity and Metabolism
Volume 14, Issue 6, pages 523–530, June 2012
How to Cite
Caterson, I. D., Finer, N., Coutinho, W., Van Gaal, L. F., Maggioni, A. P., Torp-Pedersen, C., Sharma, A. M., Legler, U. F., Shepherd, G. M., Rode, R. A., Perdok, R. J., Renz, C. L., James, W. P. T. and on behalf of the SCOUT Investigators (2012), Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. Diabetes, Obesity and Metabolism, 14: 523–530. doi: 10.1111/j.1463-1326.2011.01554.x
- Issue published online: 22 APR 2012
- Article first published online: 18 JAN 2012
- Accepted manuscript online: 22 DEC 2011 02:16PM EST
- Date submitted 3 August 2011; date of first decision 17 September 2011; date of final acceptance 15 December 2011
Additional Supporting Information may be found in the online version of this article:
Figure S1. Probability distribution functions by absolute weight loss categories from Lead-in baseline to Month 12.
Table S1. The number of subjects in each group is given in the table.
|DOM_1554_sm_fs1_ts1.doc||42K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.